Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::984787662656688128.png) @Mufaso7 Mufaso

Mufaso posts on X about $vktx, pfe, dtc, discount the most. They currently have XXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::984787662656688128/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:interactions.svg)

- X Month XXXXXX +1,744,050%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +301%

### Mentions: X [#](/creator/twitter::984787662656688128/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:posts_active.svg)


### Followers: XXXXX [#](/creator/twitter::984787662656688128/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:followers.svg)

- X Week XXXXX +1.40%
- X Months XXXXX +0.84%
- X Year XXXXX +122%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::984787662656688128/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::984787662656688128/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[$vktx](/topic/$vktx) 25%, [pfe](/topic/pfe) 12.5%, [dtc](/topic/dtc) 12.5%, [discount](/topic/discount) 12.5%, [drugs](/topic/drugs) 12.5%, [$bmy](/topic/$bmy) 12.5%, [$pfe](/topic/$pfe) 12.5%, [$lly](/topic/$lly) 12.5%, [investment](/topic/investment) 12.5%, [eli lilly](/topic/eli-lilly) XXXX%

**Top accounts mentioned or mentioned by**
[@alnafisah1994](/creator/undefined) [@krokodil_v](/creator/undefined) [@lfilipecastro](/creator/undefined) [@biopharmiq](/creator/undefined) [@glptrackerapp](/creator/undefined) [@duedoctor](/creator/undefined) [@doctor_salomon](/creator/undefined) [@fat_pockets123](/creator/undefined) [@meadowcapital](/creator/undefined) [@knielsen2000](/creator/undefined) [@brueghelelder87](/creator/undefined) [@trentkelp](/creator/undefined) [@joeyang043](/creator/undefined)

**Top assets mentioned**
[Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Pfizer, Inc. (PFE)](/topic/$pfe) [Eli Lilly and Company (LLY)](/topic/$lly)
### Top Social Posts [#](/creator/twitter::984787662656688128/posts)
---
Top posts by engagements in the last XX hours

"$VKTX- The direct to consumer channel for drugs continues to gain traction with $BMY and $PFE selling Eliquis directly to patients at a XX% discount ➡This DTC channel will continue to gain traction and enable #VK2735 to becoming a blockbuster quickly"  
![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::984787662656688128.png) [@Mufaso7](/creator/x/Mufaso7) on [X](/post/tweet/1945811561081131281) 2025-07-17 11:43:22 UTC 3229 followers, 19.7K engagements


"Lots of evidence that GLP1's have positive effects beyond Obesity/T2D. Importantly it sure seems like whenever there is a study evaluating other indications dual agonist GLP1/GIP wins every time vs mono agonist GLP1. 🤔 Here is a link to a recent study on Parkinson's: $LLY $VKTX"  
![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::984787662656688128.png) [@Mufaso7](/creator/x/Mufaso7) on [X](/post/tweet/1946884424026493064) 2025-07-20 10:46:32 UTC 3228 followers, 1829 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Mufaso7 Avatar @Mufaso7 Mufaso

Mufaso posts on X about $vktx, pfe, dtc, discount the most. They currently have XXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Month XXXXXX +1,744,050%
  • X Months XXXXXXX -XX%
  • X Year XXXXXXX +301%

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +1.40%
  • X Months XXXXX +0.84%
  • X Year XXXXX +122%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXX% finance XXXX%

Social topic influence $vktx 25%, pfe 12.5%, dtc 12.5%, discount 12.5%, drugs 12.5%, $bmy 12.5%, $pfe 12.5%, $lly 12.5%, investment 12.5%, eli lilly XXXX%

Top accounts mentioned or mentioned by @alnafisah1994 @krokodil_v @lfilipecastro @biopharmiq @glptrackerapp @duedoctor @doctor_salomon @fat_pockets123 @meadowcapital @knielsen2000 @brueghelelder87 @trentkelp @joeyang043

Top assets mentioned Viking Therapeutics, Inc (VKTX) Bristol-Myers Squibb Co (BMY) Pfizer, Inc. (PFE) Eli Lilly and Company (LLY)

Top Social Posts #

Top posts by engagements in the last XX hours

"$VKTX- The direct to consumer channel for drugs continues to gain traction with $BMY and $PFE selling Eliquis directly to patients at a XX% discount ➡This DTC channel will continue to gain traction and enable #VK2735 to becoming a blockbuster quickly"
@Mufaso7 Avatar @Mufaso7 on X 2025-07-17 11:43:22 UTC 3229 followers, 19.7K engagements

"Lots of evidence that GLP1's have positive effects beyond Obesity/T2D. Importantly it sure seems like whenever there is a study evaluating other indications dual agonist GLP1/GIP wins every time vs mono agonist GLP1. 🤔 Here is a link to a recent study on Parkinson's: $LLY $VKTX"
@Mufaso7 Avatar @Mufaso7 on X 2025-07-20 10:46:32 UTC 3228 followers, 1829 engagements

creator/x::Mufaso7
/creator/x::Mufaso7